CD8A and lung carcinoma: MDSCs negatively correlate with CD8+ T-cell expression in lung cancer patients, and MDSCs can directly induce CD8+ T cells to express T-cell exhaustion inhibitory receptors such as PD-1, TIGIT, LAG3, CTLA4, and TIM3 [5, 105, 106].